Biology – Fluid mosaic membranes | e-Consult
Fluid mosaic membranes (1 questions)
Drugs targeting cell signalling pathways can have profound effects on the target cell and the wider organism. The consequences depend heavily on the specific pathway being blocked and the role of that pathway in cellular function.
Potential Consequences:
- Disruption of Cellular Communication: Blocking a signalling pathway can prevent the cell from receiving and responding to signals from other cells. This can lead to a variety of problems, depending on the pathway.
- Altered Cell Growth and Differentiation: Many cell signalling pathways regulate cell growth, differentiation, and apoptosis (programmed cell death). Blocking these pathways can disrupt these processes, leading to uncontrolled cell growth (e.g., cancer), impaired development, or increased cell death.
- Impaired Immune Response: Immune cells rely on cell signalling pathways to communicate and coordinate their activities. Blocking these pathways can impair the immune response, making the organism more susceptible to infection.
- Metabolic Disturbances: Some cell signalling pathways regulate metabolic processes. Blocking these pathways can disrupt metabolism, leading to a variety of health problems.
- Organism-Wide Effects: Because cell signalling pathways are involved in so many different processes, blocking a pathway can have widespread effects on the organism.
Example: Imatinib (Gleevec)
Imatinib is a drug that targets the BCR-ABL tyrosine kinase pathway. This pathway is constitutively active in chronic myeloid leukemia (CML), leading to uncontrolled cell growth and proliferation. Imatinib works by binding to the ATP-binding site of the BCR-ABL kinase, preventing it from phosphorylating its target proteins and thus inhibiting cell growth.
Therapeutic Use: Imatinib is a highly effective treatment for CML. It has significantly improved the prognosis for patients with this disease, allowing many to live long and healthy lives. It is a prime example of targeted therapy, demonstrating the power of understanding cell signalling pathways to develop effective treatments for disease.